
Artificial intelligence (AI) developer Tempus and Intermountain Healthcare plan to collaborate on oncology research using genomic testing and data analytics.
Intermountain will use Tempus's solid tumor/normal genomic test, xT, to generate RNA data from existing transcriptomic samples; the RNA data will be matched with DNA data and used for oncology research, according to Tempus.